(1)Caption News – 301
image text translation
(2)Tesla CEO Elon Musk Pct1 Last Year
(3)I posted on social media that I lost more than 10kg
(4)The secret is fasting and herbal medicine
(5)This is Wiegobi, which was developed by Danish pharmaceutical company Novo Nordisk and was approved as an obesity drug
(6)Clinical trials have shown an average reduction of 15 once a week, with reports of lower cardiovascular diseasesift after a year of administration
(7)Even though the monthly cost of medicine is 2 million won because it is not covered by insurance, there is a shortage in the United States and Europe
(8)It was approved as a treatment for diabetes in Korea
(9)It’s not on the market yet due to the large volume
(10)Martin Holstranghe, vice president of Novo Nordisk
(11)It’s far above the expected demand
(12)We’ve increased production dramatically, but demand is very high
(13)Eli Lilly, a U.S. pharmaceutical company, also recently told the U.S. FDA that
(14)Diabetes drug paralysis. I applied for permission for Unzaro
(15)It’s been reported that you’ve lost an average of 26 pounds over 88 weeks
(16)The main components of both Wigobi and Mountain Jarro are GLP-1 analogs!
(17)Mechanism of action of GLP-1 analogues
(18)Ingredients of the Wiegobimounzaro
(19)→ insulin-boosting blood sugar reduction
(20)It’s a modified GLP drug that promotes the secretion of noron insulin that matches blood sugar
(21)It suppresses your appetite and makes you lose weight
(22)subtitle news
(23)Scientists are also looking into the possibility of side effects
(24)ㅜ스WODRL
(25)gastrointestinal side effects of GLP-1 drugs
(26)Published at JAMA on October 5th
(27)GLP-1 Medication Group
(28)Compared to the group taking 6 times more obesity drugs
(29)Pancreatitis incidence4
(30)an increase in powerlessness
(31)Canadian research team reveals pancreatitis incidence when administered with GLP-1 drug
(32)46 times higher, and increased gastroparalysis with reduced exercise
(33)Daniel Drucker
(34)Professor, University of Toronto, Canada
(35)”GLP-1 Drug Lease Partial Trial
(36)Patients with diabetes and obesity
(37)Another cana study, the clinical trial of the GLP-1 drug
(38)Most of them are for diabetics and obese people
(39)”It’s a GLP-1 drug
(40)Patients with diabetes and obesity
(41)If you take drugs for cosmetic purposes
(42)Lack of data such as risk!When using medication for cosmetic purposes, the result of lack of mouth is
(43)in the face of Korea
(44)I said it’s light
(45)But until now, we’ve been very concerned about these side effects
(46)It doesn’t seem to have a significant impact on the market’s preference for its medicinal properties
(47)Traditional non-psychotropic drugs, which account for most of the market, are not available
(48)GLP-1 Drugs Coming Up As A Competitor!
(49)Attention is focusing on how long the wind gusts will continue
!